Whole-exome sequencing of the BDR cohort: evidence to support the role of the PILRA gene in Alzheimer's disease

Patel, T., Brookes, K.J. ORCID: 0000-0003-2427-2513, Turton, J., Chaudhury, S., Guetta-Baranes, T., Guerreiro, R., Bras, J., Hernandez, D., Singleton, A., Francis, P.T., Hardy, J. and Morgan, K., 2018. Whole-exome sequencing of the BDR cohort: evidence to support the role of the PILRA gene in Alzheimer's disease. Neuropathology and Applied Neurobiology, 44 (5), pp. 506-521. ISSN 0305-1846

[img]
Preview
Text
13916_Brookes.pdf - Post-print

Download (146kB) | Preview

Abstract

Aim: Late-onset Alzheimer's disease (LOAD) accounts for 95% of all Alzheimer's cases and is genetically complex in nature. Overlapping clinical and neuropathological features between AD, FTD and Parkinson's disease highlight the potential role of genetic pleiotropy across diseases. Recent genome-wide association studies (GWASs) have uncovered 20 new loci for AD risk; however, these exhibit small effect sizes. Using NGS, here we perform association analyses using exome-wide and candidate-gene-driven approaches.

Methods: Whole-exome sequencing was performed on 132 AD cases and 53 control samples. Exome-wide single-variant association and gene burden tests were performed for 76 640 nonsingleton variants. Samples were also screened for known causative mutations in familial genes in AD and other dementias. Single-variant association and burden analysis was also carried out on variants in known AD and other neurological dementia genes.

Results: Tentative single-variant and burden associations were seen in several genes with kinase and protease activity. Exome-wide burden analysis also revealed significant burden of variants in PILRA (P = 3.4 × 10−5), which has previously been linked to AD via GWAS, hit ZCWPW1. Screening for causative mutations in familial AD and other dementia genes revealed no pathogenic variants. Variants identified in ABCA7, SLC24A4, CD33 and LRRK2 were nominally associated with disease (P < 0.05) but did not withstand correction for multiple testing. APOE (P = 0.02) and CLU (P = 0.04) variants showed significant burden on AD.

Conclusions: In addition, polygenic risk scores (PRS) were able to distinguish between cases and controls with 83.8% accuracy using 3268 variants, sex, age at death and APOE ε4 and ε2 status as predictors.

Item Type: Journal article
Publication Title: Neuropathology and Applied Neurobiology
Creators: Patel, T., Brookes, K.J., Turton, J., Chaudhury, S., Guetta-Baranes, T., Guerreiro, R., Bras, J., Hernandez, D., Singleton, A., Francis, P.T., Hardy, J. and Morgan, K.
Publisher: Wiley-Blackwell
Date: 2018
Volume: 44
Number: 5
ISSN: 0305-1846
Identifiers:
NumberType
10.1111/nan.12452DOI
Divisions: Schools > School of Science and Technology
Depositing User: Jonathan Gallacher
Date Added: 15 May 2019 09:37
Last Modified: 15 May 2019 09:37
URI: http://irep.ntu.ac.uk/id/eprint/36548

Actions (login required)

Edit View Edit View

Views

Views per month over past year

Downloads

Downloads per month over past year